Evaluation and validation of virus removal by ultrafiltration during the production of diaspirin crosslinked haemoglobin (DCLHb)

Biologicals

Volumn 28, Issue 2, 2000, Pages 81-94

  Azari, Mahmood ^a   Boose, Jeri Ann ^b   Burhop, Kenneth E ^a   Camacho, Theresa ^a   Catarello, James ^a   Darling, Alan ^b   Ebeling, August A ^a   Estep, Timothy N ^a   Pearson, Luisa ^b   Guzder, Sarosh ^a   Herren, Janelle ^a   Ogle, Kristen ^a   Paine, Jennifer ^a   Rohn, Kimberly ^a   Sarajari, Ramin ^a   Sun, Chong Son ^a   Zhang, Liang ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b MA BioServices Inc   (United States)

Author keywords

Diaspirin crosslinked haemoglobin (DCLHb); Haemoglobin therapeutic; Ultrafiltration; Virus removal

Indexed keywords

DIASPIRIN CROSSLINKED HEMOGLOBIN; PHOSPHATE; SODIUM CHLORIDE;

ARTICLE; BLOOD FILTRATION; BOVINE DIARRHEA VIRUS; CONTROLLED STUDY; ENCEPHALOMYOCARDITIS VIRUS; FLOW RATE; HEMOLYSATE; HEPATITIS A VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MEMBRANE FILTER; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PSEUDORABIES HERPETOVIRUS; ULTRAFILTRATION; VALIDATION PROCESS; VIRUS ISOLATION; VIRUS LOAD;

BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1; EMC VIRUS; ENCEPHALOMYOCARDITIS VIRUS; HEPATITIS A VIRUS; HERPETOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; PARVOVIRUS; PORCINE PARVOVIRUS; SUID HERPESVIRUS 1; SUIDAE;

EID: 0033764599     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.2000.0246     Document Type: Article

References (11)

1. 2)
2. A hemoglobin derivative that is cross-linked between the a subunits is useful as a blood substitute
3. Preparation and characterization of diaspirin cross-linked hemoglobin solutions for preclinical studies
4. The risk of transfusion-transmitted viral infections
5. Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb) for viral inactivation
6. Size exclusion removal of model mammalian viruses using a unique membrane system, Part II: Module qualification and process simulation
7. Nanofiltration, a new specific virus elimination method applied to high-purity factor IX and factor XI concentrates
8. Theoretical analysis of pore size distribution effects on membrane transport